+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2023-2030

  • PDF Icon

    Report

  • 129 Pages
  • June 2023
  • Region: Global
  • Grand View Research
  • ID: 4479762
Description Jump to:
The global neglected tropical diseases diagnosis market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.5% during the forecast period, according to this report. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Increasing concern regarding neglected tropical diseases and their impact on the population as well as economies has boosted the demand for the development of early disease detection methods. This growth in concern is evident in the launch of a substantial number of programs aiming to combat NTDs. For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. In January 2021, Novartis AG signed an agreement with the WHO to manage leprosy across the globe. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

According to the WHO, as of January 2022, more than 1.5 billion people are infected with soil-transmitted helminth infections worldwide. The Kato-Katz technique is the WHO gold standard that is widely used to diagnose the intensity of STHs. These infections are distributed widely in tropical and subtropical areas majorly occurring in America, sub-Saharan Africa, East Asia, and China. Furthermore, the presence of key players is expected to fuel the overall market growth. The involvement of these players in new product development is considered to be the contributing factor to the development of the NTD diagnosis market.

Neglected Tropical Disease Diagnosis Market Report Highlights

  • By disease type, the soil-transmitted helminthiases dominated the market in 2022, owing to the increasing prevalence and high adoption of diagnostics tests
  • The molecular/modern diagnostic segment dominated the market in 2022, owing to an increase in R&D for molecular diagnostic techniques coupled with a rise in demand for point-of-care products
  • Centralized service accounted for the largest segment in terms of market share in 2022 due to high procedure volume and the wide presence of ancillary support in terms of infrastructure and manpower
  • By end-use, home healthcare is expected to be the fastest-growing segment as a result of the growing popularity and demand for POCT services
  • Asia Pacific dominated the global market in 2022, owing to the high disease burden of NTDs, increased healthcare expenditure, rapid technological advancements, and a rise in customer awareness about the use of PCR tests in diagnosing NTDs
  • Latin America is expected to grow considerably in the future, owing to increased IVD product penetration and the high disease burden of NTDs in developing countries

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of neglected tropical diseases
3.2.1.2. Growing investments and governmental funding in the development of diagnostics
3.2.1.3. Growing awareness of neglected tropical diseases
3.2.2. Market Restraint Analysis
3.2.2.1. Shift of funds to tackle other diseases in low health budgets
3.2.2.2. Shortage of funding from international partners and foreign government
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Disease Business Analysis
4.1. Neglected Tropical Disease Diagnosis Market: Disease Movement Analysis
4.2. Dengue
4.2.1. Dengue Market, 2018 - 2030 (USD Million)
4.3. Chikungunya
4.3.1. Chikungunya Market, 2018 - 2030 (USD Million)
4.4. Rabies
4.4.1. Rabies Market, 2018 - 2030 (USD Million)
4.5. Leprosy
4.5.1. Leprosy Market, 2018 - 2030 (USD Million)
4.6. Buruli Ulcer
4.6.1. Buruli Ulcer Market, 2018 - 2030 (USD Million)
4.7. Yaws
4.7.1. Yaws Market, 2018 - 2030 (USD Million)
4.8. Lymphatic Filariasis
4.8.1. Lymphatic Filariasis Market, 2018 - 2030 (USD Million)
4.9. Taeniasis/Cysticercosis
4.9.1. Taeniasis/Cysticercosis Market, 2018 - 2030 (USD Million)
4.10. Foodborne Trematode Infections
4.10.1. Foodborne Trematode Infections Market, 2018 - 2030 (USD Million)
4.11. Echinococcosis
4.11.1. Echinococcosis Market, 2018 - 2030 (USD Million)
4.12. Chagas Disease
4.12.1. Chagas Disease Market, 2018 - 2030 (USD Million)
4.13. Dracunculiasis
4.13.1. Dracunculiasis Market, 2018 - 2030 (USD Million)
4.14. Human African Trypanosomiasis (Sleeping Sickness)
4.14.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2018 - 2030 (USD Million)
4.15. Soil-Transmitted Helminthiases
4.15.1. Soil-Transmitted Helminthiases Market, 2018 - 2030 (USD Million)
4.16. Onchocerciasis
4.16.1. Onchocerciasis Market, 2018 - 2030 (USD Million)
4.17. Schistosomiasis
4.17.1. Schistosomiasis Market, 2018 - 2030 (USD Million)
4.18. Scabies and Other Ecoparasites
4.18.1. Scabies and Other Ecoparasites Market, 2018 - 2030 (USD Million)
4.19. Snakebite Envenoming
4.19.1. Snakebite Envenoming Market, 2018 - 2030 (USD Million)
4.20. Leishmaniases
4.20.1. Leishmaniases Market, 2018 - 2030 (USD Million)
Chapter 5. Diagnostic Method Business Analysis
5.1. Neglected Tropical Disease Diagnosis Market: Diagnostic Method Movement Analysis
5.2. Conventional Method
5.2.1. Conventional Method Market, 2018 - 2030 (USD Million)
5.3. Molecular/Modern Method
5.3.1. Molecular/Modern Method Market, 2018 - 2030 (USD Million)
Chapter 6. Service Type Business Analysis
6.1. Neglected Tropical Disease Diagnosis Market: Service Type Movement Analysis
6.2. Centralized Service
6.2.1. Centralized Service Market, 2018 - 2030 (USD Million)
6.3. POC Service
6.3.1. POC Service Market, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
7.1. Neglected Tropical Disease Diagnosis Market: End-Use Movement Analysis
7.2. Clinical Labs
7.2.1. Clinical Labs Market, 2018 - 2030 (USD Million)
7.2.2. Hospital/Clinics
7.2.2.1. Hospital/Clinics Market, 2018 - 2030 (USD Million)
7.2.3. Home Healthcare
7.2.3.1. Home Healthcare Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Neglected Tropical Disease Diagnosis Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. UK Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.3.4. Germany
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Germany Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. China Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. India Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.4.5. Indonesia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Indonesia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.4.6. Malaysia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Malaysia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Brazil Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.5.4. Colombia
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Colombia Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.5.5. Venezuela
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Competitive Scenario
8.5.5.4. Regulatory Framework
8.5.5.5. Venezuela Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
8.6.3. Nigeria
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Nigeria Neglected Tropical Disease Diagnosis Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Abbott
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. ZeptoMetrix, LLC
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. InBios International, Inc.
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Genome Diagnostics Pvt. Ltd.
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Omega Diagnostics Group PLC
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Coris BioConcept
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. DiaSys Diagnostic Systems GmbH
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. GmbH Oscar Medicare Pvt Ltd.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviation
Table 3: Global Neglected Tropical Diseases Diagnosis Market, By Region, 2018-2030 (USD Million)
Table 4: Global Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 5: Global Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 6: Global Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 7: Global Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 8: North America Neglected Tropical Diseases Diagnosis Market, By Country, 2018-2030 (USD Million)
Table 9: North America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 10: North America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 11: North America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 12: North America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 13: U.S. Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 14: U.S. Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 15: U.S. Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 16: U.S. Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 17: Canada Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 18: Canada Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 19: Canada Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 20: Canada Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 21: Europe Neglected Tropical Diseases Diagnosis Market, By Country, 2018-2030 (USD Million)
Table 22: Europe Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 23: Europe Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 24: Europe Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 25: Europe Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 26: UK Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 27: UK Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 28: UK Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 29: UK Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 30: Germany Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 31: Germany Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 32: Germany Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 33: Germany Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 34: Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Country, 2018-2030 (USD Million)
Table 35: Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 36: Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 37: Asia Pacific Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 38: Asia Pacific Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 39: China Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 40: China Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 41: China Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 42: China Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 43: India Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 44: India Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 45: India Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 46: India Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 47: Indonesia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 48: Indonesia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 49: Indonesia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 50: Indonesia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 51: Malaysia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 52: Malaysia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 53: Malaysia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 54: Malaysia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 55: Latin America Neglected Tropical Diseases Diagnosis Market, By Country, 2018-2030 (USD Million)
Table 56: Latin America Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 57: Latin America Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 58: Latin America Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 59: Latin America Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 60: Brazil Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 61: Brazil Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 62: Brazil Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 63: Brazil Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 64: Colombia Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 65: Colombia Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 66: Colombia Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 67: Colombia Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 68: Venezuela Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 69: Venezuela Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 70: Venezuela Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 71: Venezuela Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 72: Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Country, 2018-2030 (USD Million)
Table 73: Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 74: Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 75: Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 76: Middle East & Africa Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
Table 77: Nigeria Neglected Tropical Diseases Diagnosis Market, By Disease, 2018-2030 (USD Million)
Table 78: Nigeria Neglected Tropical Diseases Diagnosis Market, By Diagnostic Method, 2018-2030 (USD Million)
Table 79: Nigeria Neglected Tropical Diseases Diagnosis Market, By Service Type, 2018-2030 (USD Million)
Table 80: Nigeria Neglected Tropical Diseases Diagnosis Market, By End-Use, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market Research Process
Fig. 2: Information Procurement
Fig. 3: Primary Research Pattern
Fig. 4: Market Research Approaches
Fig. 5: Value Chain-Based Sizing & Forecasting
Fig. 6: Market Formulation & Validation
Fig. 7: Neglected Tropical Diseases Diagnosis Market Segmentation
Fig. 8: Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9: Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10: Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11: Penetration & Growth Prospect Mapping
Fig. 12: SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13: Porter’s Five Forces Analysis
Fig. 14: Neglected tropical diseases diagnosis market: Disease outlook and key takeaways
Fig. 15: Neglected tropical diseases diagnosis market: Disease movement analysis & market share 2022 & 2030
Fig. 16: Dengue neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 17: Chikungunya neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 18: Rabies market, 2018-2030 (USD Million)
Fig. 19: Leprosy neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 20: Buruli ulcer neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 21: Yaws market, 2018-2030 (USD Million)
Fig. 22: Lymphatic filariasis neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 23: Taeniasis/Cysticercosis neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 24: Foodborne trematode infections market, 2018-2030 (USD Million)
Fig. 25: Echinococcosis neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 26: Chagas disease neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 27: Dracunculiasis market, 2018-2030 (USD Million)
Fig. 28: Human African trypanosomiasis (sleeping sickness) neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 29: Soil-transmitted helminthiases neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 30: Onchocerciasis market, 2018-2030 (USD Million)
Fig. 31: Schistosomiasis neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 32: Scabies and other ecoparasites neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 33: Snakebite envenoming market, 2018-2030 (USD Million)
Fig. 34: Leishmaniases market, 2018-2030 (USD Million)
Fig. 35: Neglected tropical diseases diagnosis market: Diagnostic method outlook and key takeaways
Fig. 36: Neglected tropical diseases diagnosis market: Diagnostic method movement analysis & market share 2022 & 2030
Fig. 37: Conventional method market, 2018-2030 (USD Million)
Fig. 38: Molecular/Modern method market, 2018-2030 (USD Million)
Fig. 39: Neglected tropical diseases diagnosis market: Service type outlook and key takeaways
Fig. 40: Neglected tropical diseases diagnosis market: Service type movement analysis & market share 2022 & 2030
Fig. 41: Centralized service neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 42: POC service neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 43: Neglected tropical diseases diagnosis market: End-Use outlook and key takeaways
Fig. 44: Neglected tropical diseases diagnosis market: End-Use movement analysis & market share 2022 & 2030
Fig. 45: Clinical labs neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 46: Hospitals/Clinics neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 47: Home healthcare neglected tropical diseases diagnosis market, 2018-2030 (USD Million)
Fig. 48: Regional Marketplace: Key Takeaways
Fig. 49: Regional Outlook, 2022 & 2030
Fig. 50: Regional Market Dashboard
Fig. 51: Regional Market Place: Key Takeaways
Fig. 52: North America, SWOT Analysis
Fig. 53: Europe, SWOT Analysis
Fig. 54: Asia Pacific, SWOT Analysis
Fig. 55: Latin America, SWOT Analysis
Fig. 56: MEA, SWOT Analysis
Fig. 57: North America
Fig. 58: North America Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 59: U.S.
Fig. 60: U.S. Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 61: Canada
Fig. 62: Canada Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 63: Europe
Fig. 64: Europe Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 65: UK
Fig. 66: UK Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 67: Germany
Fig. 68: Germany Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 69: Asia Pacific
Fig. 70: Asia-Pacific Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 71: China
Fig. 72: China Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 73: India
Fig. 74: India Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 75: Indonesia
Fig. 76: Indonesia Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 77: Malaysia
Fig. 78: Malaysia Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 79: Latin America
Fig. 80: Latin America Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 81: Brazil
Fig. 82: Brazil Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 83: Colombia
Fig. 84: Colombia Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 85: MEA
Fig. 86: MEA Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 87: Nigeria
Fig. 88: Nigeria Market Estimates And Forecast, 2018-2030 (USD Million)
Fig. 89: Strategy Mapping

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix, LLC
  • InBios International, Inc.
  • Genome Diagnostics Pvt. Ltd.
  • Omega Diagnostics Group PLC
  • Coris BioConcept
  • DiaSys Diagnostic Systems GmbH
  • GmbH Oscar Medicare Pvt Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages129
PublishedJune 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 6.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.97 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Neglected Tropical Diseases Diagnosis Market by Service, Disease, Diagnostic Method, End-Use - Global Forecast 2025-2030 - Product Image

Neglected Tropical Diseases Diagnosis Market by Service, Disease, Diagnostic Method, End-Use - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Neglected Tropical Disease Treatment Market by Product, Types of Diseases, Diagnostic Method - Global Forecast 2025-2030 - Product Image

Neglected Tropical Disease Treatment Market by Product, Types of Diseases, Diagnostic Method - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Neglected Tropical Disease Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Neglected Tropical Disease Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Neglected Tropical Diseases Diagnosis - Global Strategic Business Report - Product Image

Neglected Tropical Diseases Diagnosis - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Neglected Tropical Diseases Diagnosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Neglected Tropical Diseases Diagnosis Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.